Anti-Retropulsion Devices Market Report 2026
Global Outlook – By Product Type (Basket Type Anti-Retropulsion Devices, Balloon Type Anti-Retropulsion Devices, Mechanical Retropulsion Devices), By Application (Ureteroscopy, Lithotripsy), By End-User (Hospitals, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Anti-Retropulsion Devices Market Overview
• Anti-Retropulsion Devices market size has reached to $2.56 billion in 2025 • Expected to grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Impact Of Rising Kidney Stone Prevalence On The Anti-Retropulsion Device Market • Market Trend: Technological Advancements Drive Efficiency In Anti-Retropulsion Device Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Anti-Retropulsion Devices Market?
Anti-retropulsion devices refer to instruments or tools used during medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter toward the kidney during lithotripsy or other stone removal procedures. These devices are designed to stabilize stones or stone fragments within the urinary tract, facilitating their passage or extraction without causing obstruction or additional complications. The main product types of anti-retropulsion devices include basket-type anti-retropulsion devices, balloon-type anti-retropulsion devices, and others. Basket-type anti-retropulsion devices are specialized medical tools used during urological procedures to capture and remove kidney stones or stone fragments. The applications include ureteroscopy, lithotripsy, and end uses, which include hospitals, ambulatory surgical centers, and others.
What Is The Anti-Retropulsion Devices Market Size and Share 2026?
The anti-retropulsion devices market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising incidence of kidney stones and urolithiasis, increasing adoption of ureteroscopy and lithotripsy procedures, early availability of basket and balloon anti-retropulsion devices, growth in hospital-based urology surgery volumes, increasing focus on stone clearance efficiency.What Is The Anti-Retropulsion Devices Market Growth Forecast?
The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for minimally invasive stone removal technologies, increasing use of disposable anti-retropulsion devices, growth in ambulatory stone treatment procedures, expanding development of specialized device designs for complex stones, increasing investments in urology care infrastructure. Major trends in the forecast period include rising preference for advanced anti-retropulsion devices to improve stone stabilization during lithotripsy, increasing utilization of basket and balloon-type devices to minimize proximal stone migration, growing clinical shift toward minimally invasive ureteroscopy-based stone management, expanding adoption of procedure-specific device designs for complex ureteral anatomies, increasing demand for disposable and single-use anti-retropulsion devices to reduce infection risk.
Global Anti-Retropulsion Devices Market Segmentation
1) By Product Type: Basket Type Anti-Retropulsion Devices, Balloon Type Anti-Retropulsion Devices, Mechanical Retropulsion Devices 2) By Application: Ureteroscopy, Lithotripsy 3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Basket Type Anti-Retropulsion Devices: Self-Expanding Basket Devices, Balloon-Expandable Basket Devices, Balloon Type Anti-Retropulsion Devices, 2) By Balloon Type Anti-Retropulsion Devices: Single-Lumen Balloon Devices, Multi-Lumen Balloon Devices, Other Anti-Retropulsion Devices, 3) By Mechanical Retropulsion Devices: Mechanical Retropulsion Devices, Stent-Based Anti-Retropulsion Devices.What Is The Driver Of The Anti-Retropulsion Devices Market?
The rising prevalence of chronic kidney disease is expected to propel the growth of the anti-retropulsion device market going forward. Chronic kidney diseases refer to a diverse range of conditions that affect the structure and operation of the kidneys. Poor diet, sedentary behavior, obesity, smoking, and excessive alcohol use all contribute to the growth of renal problems. Anti-retropulsion devices are used to enhance the effectiveness of urological procedures by preventing kidney stone fragments from migrating back towards the kidney during treatment. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a U.S.-based public health agency, the prevalence of chronic kidney disease among adults in the United States was estimated at over 14%, affecting approximately 35.5 million people, up from 13% in 2023. Therefore, the rising prevalence of chronic kidney disease will drive the growth of the anti-retropulsion device industry.Key Players In The Global Anti-Retropulsion Devices Market
Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Cook Medical Incorporated, KARL STORZ SE & Co KG, Coloplast A/S, ROCAMED SAM, Endotherapeutics Pty Ltd, Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., NeoScope Inc, OTU Medical, Clarion Medical Technologies, Calyxo Inc, EMS Urology, Happiness Works Medical, PENTAX Medical, UROMED Kurt Drews KG, EndoTheia Inc, Maxer Endoscopy GmbH
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Anti-Retropulsion Devices Market Trends and Insights
Major companies operating in the anti-retropulsion device market are focusing on design improvements and user-centric innovations, such as vacuum-assisted kidney stone removal devices, to improve patient outcomes and reduce procedural times. Vacuum-assisted kidney stone removal devices are medical tools designed to enhance the efficiency of urological procedures by using suction to capture and remove kidney stones from the urinary tract. For instance, in March 2024, Calyxo, Inc., a US-based medical device company focused on improving care for patients with kidney stones, launched the CVAC System, a comprehensive solution engineered for efficient and effective kidney stone removal, utilizing irrigation and vacuum aspiration to continuously clear stone fragments during and after laser lithotripsy, thereby enabling physicians to achieve stone-free outcomes.What Are Latest Mergers And Acquisitions In The Anti-Retropulsion Devices Market?
In June 2024, The Medical City, a Philippines-based hospital, acquired Lumenis Moses 2.0 machine for an undisclosed amount. The acquisition aims to strengthen The Medical City's position as a leader in urological services by providing advanced, minimally invasive treatment options for kidney stones and benign prostate enlargement (BPH). It seeks to improve patient outcomes through enhanced precision, efficiency, and reduced recovery times. Lumenis Ltd. an Israel-based company that specializes in providing anti- retropulsion devices.
Regional Outlook
North America was the largest region in the anti-retropulsion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Anti-Retropulsion Devices Market?
The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Anti-Retropulsion Devices Market Report 2026?
The anti-retropulsion devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Anti-Retropulsion Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.75 billion |
| Revenue Forecast In 2030 | $3.51 billion |
| Growth Rate | CAGR of 6.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Cook Medical Incorporated, KARL STORZ SE & Co KG, Coloplast A/S, ROCAMED SAM, Endotherapeutics Pty Ltd, Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., NeoScope Inc, OTU Medical, Clarion Medical Technologies, Calyxo Inc, EMS Urology, Happiness Works Medical, PENTAX Medical, UROMED Kurt Drews KG, EndoTheia Inc, Maxer Endoscopy GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |